https://www.nasdaq.com/press-release/biovie-to-participate-at-the-lifesci-partners-11th-annual-corporate-access-event-2021
https://www.nasdaq.com/press-release/biovie-announces-partnership-with-the-american-liver-foundation-2021-12-09
https://www.nasdaq.com/press-release/biovie-secures-up-to-a-%2425.0-million-debt-facility-with-avenue-venture-opportunities
https://www.nasdaq.com/press-release/biovie-hosting-key-opinion-leader-webinar-on-complications-of-advanced-liver
https://www.nasdaq.com/press-release/biovie-announces-the-appointment-of-a-new-chief-medical-officer-2021-11-01
https://www.nasdaq.com/press-release/biovie-announces-fda-authorization-to-initiate-phase-2-trials-assessing-ne3107s-pro
https://www.nasdaq.com/press-release/biovie-hosting-key-opinion-leader-webinar-on-neuroinflammation-and-insulin-resistance
https://www.nasdaq.com/press-release/biovie-to-present-at-cantor-virtual-global-healthcare-conference-2021-09-22
https://www.nasdaq.com/press-release/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-virtual-summit
https://www.nasdaq.com/press-release/biovie-inc.-announces-closing-of-public-offering-of-common-stock-2021-08-11
https://www.nasdaq.com/press-release/biovie-inc.-announces-pricing-of-public-offering-of-common-stock-2021-08-08
https://www.nasdaq.com/press-release/biovie-inc.-announces-proposed-public-offering-of-common-stock-2021-08-06
https://www.nasdaq.com/press-release/biovie-announces-first-patient-enrolled-in-phase-3-study-of-ne3107-in-alzheimers
https://www.nasdaq.com/press-release/biovie-presents-data-supporting-use-of-ne3107-in-the-treatment-of-alzheimers-disease
https://www.nasdaq.com/press-release/biovie-to-present-rationale-for-use-of-ne3107-for-the-treatment-of-alzheimers-disease
https://www.nasdaq.com/press-release/basis-for-biovies-phase-3-clinical-trial-of-ne3107-in-the-treatment-of-alzheimers
https://www.nasdaq.com/press-release/development-of-biovies-ne3107-asset-featured-by-the-american-diabetes-association
https://www.nasdaq.com/press-release/biovie-added-to-russell-microcapr-index-2021-06-28
https://www.nasdaq.com/press-release/biovie-interview-to-air-on-bloomberg-television-u.s.-on-the-redchip-money-reportr-0
https://www.nasdaq.com/press-release/biovie-announces-first-patient-enrolled-in-biv201-phase-2b-clinical-trial-for-ascites
https://www.nasdaq.com/press-release/biovie-receives-fda-guidance-for-phase-3-clinical-trial-of-biv201-in-hrs-aki-2021-06
https://www.nasdaq.com/press-release/biovie-interview-to-air-on-bloomberg-television-u.s.-on-the-redchip-money-reportr
https://www.nasdaq.com/press-release/biovie-announces-closing-of-acquisition-of-biopharma-assets-from-privately-held
https://www.nasdaq.com/press-release/biovie-hosting-research-development-day-2021-05-13
https://www.nasdaq.com/press-release/biovie-announces-amended-terms-for-asset-acquisition-from-privately-held-neurmedix
https://www.nasdaq.com/press-release/biovie-to-present-at-2021-b.-riley-securities-neuroscience-conference-2021-04-28
https://www.nasdaq.com/press-release/biovie-acquires-biopharma-assets-from-privately-held-neurmedix-2021-04-27
https://www.nasdaq.com/press-release/biovie-to-present-at-31st-annual-oppenheimer-healthcare-conference-2021-03-11
https://www.nasdaq.com/press-release/biovie-commences-patient-screening-in-phase-2-clinical-trial-2021-03-09
https://www.nasdaq.com/press-release/biovie-interview-to-air-on-bloomberg-tv-in-the-us-on-the-redchip-money-reportr-2021
https://www.nasdaq.com/press-release/biovie-interview-to-air-on-bloomberg-international-on-the-redchip-money-report-2020
https://www.nasdaq.com/press-release/biovie-to-participate-in-b.-riley-securities-liver-disease-therapeutics-day-on
https://www.nasdaq.com/press-release/biovie-announces-closing-of-public-offering-of-common-stock-2020-09-23
https://www.nasdaq.com/press-release/biovie-to-present-at-oppenheimer-fall-healthcare-life-sciences-medtech-summit-2020-09
https://www.nasdaq.com/press-release/biovie-inc.-announces-nasdaq-listing-and-pricing-of-%2415.7-million-public-offering
https://www.nasdaq.com/press-release/highly-accomplished-executives-join-biovies-board-of-directors-2020-06-16
